Durvalumab with chemotherapy as first line treatment in advanced pleural mesothelioma: A phase 3, randomised trial (DREAM3R).

被引：0
|
作者：
Forde, Patrick M.
Nowak, Anna K.
Hughes, Brett Gordon Maxwell
Kok, Peey Sei
Brown, Chris
Sun, Zhuoxin
Anagnostou, Valsamo
O'Byrne, Ken
Yip, Sonia
Cook, Alistair
Lesterhuis, Willem Joost
Pavlakis, Nick
Brahmer, Julie R.
Kindler, Hedy L.
Tsao, Anne S.
Zauderer, Marjorie Glass
Ramalingam, Suresh S.
Stockler, Martin R.
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA
[2] Univ Western Australia, Nedlands, WA, Australia
[3] Prince Charles Hosp, Brisbane, Qld, Australia
[4] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Johns Hopkins Kimmel Canc Ctr, Baltimore, MD USA
[7] Queensland Univ Technol, Princess Alexandra Hosp, Translat Res Inst, Brisbane, Qld, Australia
[8] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[9] Univ Western Australia, Sch Med, Perth, WA, Australia
[10] Univ Western Australia, Natl Ctr Asbestos Related Dis, Perth, WA, Australia
[11] Univ Western Australia, Natl Ctr Asbestos Related Dis, Nedlands, WA, Australia
[12] North Shore Hlth Hub, Genesis Care, Sydney, NSW, Australia
[13] Johns Hopkins Kimmel Canc Ctr, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA
[14] Univ Chicago, Chicago, IL 60637 USA
[15] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[16] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[17] Emory Univ Hosp, Winship Canc Inst, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS8599
引用
收藏
页数：1
相关论文
共 50 条
  • [1] DREAM3R: DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma: A Phase 3 Randomised Trial
    Forde, P.
    Kindler, H.
    Zauderer, M.
    Sun, Z.
    Ramalingam, S.
    Anagnostou, V.
    Brahmer, J. R.
    Nowak, A. K.
    Kok, P. S.
    Brown, C.
    Yip, S.
    Cook, A.
    Lesterhuis, W. J.
    Hughes, B. G. M.
    Pavlakis, N.
    Stockler, M. R.
    O'Byrne, K. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (02): : E9 - E10
  • [2] DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
    Forde, P.
    Stockler, M.
    Kok, P. S.
    Brown, C.
    Sun, Z.
    O'Byrne, K.
    Yip, S.
    Anagnostou, V.
    Cook, A.
    Lesterhuis, W. J.
    Hughes, B.
    Kindler, H.
    Tsao, A.
    Zauderer, M.
    Bricker, A.
    Oostendorp, M.
    Marinucci, D.
    Fitzpatrick, K.
    Ford, K.
    Pavlakis, N.
    Brahmer, J.
    Ramalingam, S.
    Nowak, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S957 - S957
  • [3] DuRvalumab with chEmotherapy as first line treAtment in advanced pleural Mesothelioma: A phase 3 randomised trial. The DREAM3R trial
    John, Thomas
    Forde, Patrick
    Kok, Peey Sei
    Brown, Chris
    Sun, Zhuoxin
    O'Byrne, Kenneth
    Yip, Sonia
    Anagnostou, Valasamo
    Cook, Alistair
    Lesterhuis, Willem J.
    Hughes, Brett G. M.
    Johnson, Lisa
    Oostendorp, Martijn
    Marinucci, Donna
    Fitzpatrick, Karen
    Ford, Kate
    Pavlakis, Nick
    Brahmer, Julie
    Stockler, Martin R.
    Ramalingam, Suresh
    Nowak, Anna
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 205 - 206
  • [4] Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma - a phase 3 randomised trial
    Kok, Peey Sei
    Forde, Patrick M.
    Hughes, Brett
    Sun, Zhuoxin
    Brown, Chris
    Ramalingam, Suresh
    Cook, Alistair
    Lesterhuis, Willem Joost
    Yip, Sonia
    O'Byrne, Ken
    Pavlakis, Nick
    Brahmer, Julie
    Anagnostou, Valsamo
    Ford, Kate
    Fitzpatrick, Karen
    Bricker, Alison
    Cummins, Michelle M.
    Stockler, Martin
    Nowak, Anna K.
    BMJ OPEN, 2022, 12 (01):
  • [5] DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma-A phase 3 randomized trial.
    Forde, Patrick M.
    Nowak, Anna K.
    Kok, Peey-Sei
    Brown, Chris
    Sun, Zhuoxin
    Anagnostou, Valsamo
    O'Byrne, Kenneth John
    Yip, Sonia
    Cook, Alistair
    Lesterhuis, Willem Joost
    Hughes, Brett Gordon Maxwell
    Pavlakis, Nick
    Brahmer, Julie R.
    Kindler, Hedy L.
    Tsao, Anne S.
    Zauderer, Marjorie Glass
    Ramalingam, Suresh S.
    Stockler, Martin R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] DREAM3R: Durvalumab with chemotherapy as firstline treatment in advanced pleural mesothelioma-A phase 3 randomized trial.
    Forde, Patrick M.
    Nowak, Anna K.
    Kok, Peey-Sei
    Brown, Chris
    Sun, Zhuoxin
    Anagnostou, Valsamo
    O'Byrne, Kenneth John
    Yip, Sonia
    Cook, Alistair
    Lesterhuis, Willem Joost
    Hughes, Brett Gordon Maxwell
    Pavlakis, Nick
    Brahmer, Julie R.
    Tsao, Hedy L. Kindler Anne S.
    Zauderer, Marjorie Glass
    Ramalingam, Suresh S.
    Stockler, Martin R.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In
    Nowak, Anna
    Kok, Peey-Sei
    Livingstone, Ann
    Lesterhuis, Willem Joost
    Yip, Sonia
    Donoghoe, Mark
    Lam, Wei-Sen
    Stockler, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1086 - S1087
  • [8] DREAM - A Phase 2 Trial of Durvalumab with First Line Chemotherapy in Mesothelioma: Final Result
    Nowak, A.
    Kok, P.
    Lesterhuis, W.
    Hughes, B.
    Brown, C.
    Kao, S.
    Karikios, D.
    John, T.
    Pavlakis, N.
    O'Byrne, K.
    Yip, S.
    Lam, W.
    Briscoe, K.
    Karapetis, C.
    Stockler, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S338 - S339
  • [9] DREAM - a phase 2 trial of DuRvalumab with first line chEmotherApy in mesothelioma: final result
    Kok, Peey-Sei
    Stockler, Martin
    Lesterhuis, Willem
    Hughes, Brett
    Brown, Chris
    Kao, Steven Chuan-Hao
    Karikios, Deme
    John, Thomas
    Pavlakis, Nick
    O'Byrne, Keno
    Yip, Sonia
    Lam, Wei-Sen
    Briscoe, Karen
    Karapetis, Chris
    Nowak, Anna
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 83 - 84
  • [10] DREAM: A phase II study of durvalumab with first line chemotherapy in mesothelioma-First results.
    Nowak, Anna K.
    Lesterhuis, Willem Joost
    Hughes, Brett Gordon Maxwell
    Brown, Chris
    Kok, Peey Sei
    O'Byrne, Kenneth John
    John, Tom
    Pavlakis, Nick
    Kao, Steven Chuan-Hao
    Yip, Sonia
    Karikios, Deme John
    Lam, Wei-Sen
    Langford, Ailsa
    Stockler, Martin R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345